RxDoctor Payments DataLook up a doctor →

Albert Denittis, MD

Radiation Oncology · Wynnewood, PANPI 1134129349

Payments from drug & device makers

$32,634in general payments, 2019–2025

Across 188 payments — averaging $173.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novocure GmbH$25K
  • Merck$4K
  • Johnson & Johnson$668
  • Astellas Pharma US Inc$432
  • Janssen Scientific Affairs, LLC$293
  • Novartis$283
  • plus $3K from 37 others

What the payments were for

  • Food & beverage$4,56099%
  • Education$311%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,634 in reported general payments places this provider in the 85th percentile of 339 radiation oncology providers in Pennsylvania.

See all radiation oncology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$1,195,126
Medicare patients
130
Services billed
4,780

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl72$697

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Wynnewood

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →